SNGX
SNGX
NASDAQ · Biotechnology

Soligenix Inc

$0.40
+0.00 (+0.75%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +10,031.5% upside
Low Target $24.77
Average Target $40.83
High Target $47.84
Current Price $0.40
Current
$0.40
Target
$40.83
$24.77 $40.83 avg $47.84
Scenario Analysis
Bear Case
$24.77
6,046.4%
Low target
Base Case
$40.83
+10,031.5%
Avg target
Bull Case
$47.84
+11,771.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.23
-93.5% from high
52-Week Low
$0.28
+43.9% from low
Target vs 52W High
$40.83
+555.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%